THALIDOMIDE TREATMENT PREVENTS CHRONIC GRAFT REJECTION AFTER AORTIC TRANSPLANTATION IN RATS

BACKGROUND: Cardiac allograft vasculopathy (CAV) affects approximately 30% of cardiac transplant patients at five years post-transplantation. To date there are few CAV treatment or prevention options, none of which are highly effective. The aim of the study was to investigate the effect of thalidomi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transpl Int
Autores principales: Miller, Katharine K., Wang, Dong, Hu, Xiaomeng, Hua, Xiaoqin, Deuse, Tobias, Neofytou, Evgenios, Renne, Thomas, Velden, Joachim, Reichenspurner, Hermann, Schrepfer, Sonja, Bernstein, Daniel
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643223/
https://ncbi.nlm.nih.gov/pubmed/28672061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares